ArticleCancers2019

Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes.

Bryce Demoret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.